23andMe Gets Snubbed As Wirecutter Ranks Ancestry Testing Services
Anne Wojcicki, the CEO of 23andMe. Image by Getty
By Ari Feldman September 5, 2017
The Wirecutter, a popular product recommendation site, recently offered reviews about the leading genetic ancestry testing services. The big surprise? 23andMe, the popular genomics company, was not listed as a top pick. Instead, the site ranked Ancestry.com and Family Tree DNA as the best picks.
The Wirecutter’s decision not to recommend 23andMe had to do with how the company collects biomedical data about its customers. The basic testing kit from 23andMe gives results about your ancestry and costs $100. According to the Wirecutter’s research, however, 23andMe tests for both your ancestry and your genetic health when you send them your saliva. Though receiving the health results — indicating whether you may have a hereditary risk for a particular disease, for example — costs an additional $100, 23andMe can sell your biomedical data if you haven’t purchased the health test.
“The problem is that if you’ve paid for just the ancestry test and signed the consent form, you’ve granted access not just to your ancestry data but to your biomedical data, which you’d have no reasonable way of knowing was even obtained,” the Wirecutter wrote.
A spokeswoman for 23andMe said that it performs both the ancestry and health tests when they receive your saliva as a convenience — so that if you decide later you want the health test in addition to the ancestry test, they already have the results on file.
23andMe recently posted a discredited theory about the genetic heritage of Ashekenazi Jews on its website, telling some users that they may descended from a semi-nomadic tribe from Central Asia.
Contact Ari Feldman at [email protected] or on Twitter @aefeldman.
This is a moment of great uncertainty. Here’s what you can do about it.
We hope you appreciated this article. Before you go, we’d like to ask you to please support the Forward’s independent Jewish news this Passover. All donations are being matched by the Forward Board - up to $100,000.
This is a moment of great uncertainty for the news media, for the Jewish people, and for our sacred democracy. It is a time of confusion and declining trust in public institutions. An era in which we need humans to report facts, conduct investigations that hold power to account, tell stories that matter and share honest discourse on all that divides us.
With no paywall or subscriptions, the Forward is entirely supported by readers like you. Every dollar you give this Passover is invested in the future of the Forward — and telling the American Jewish story fully and fairly.
The Forward doesn’t rely on funding from institutions like governments or your local Jewish federation. There are thousands of readers like you who give us $18 or $36 or $100 each month or year.
Support our mission to tell the Jewish story fully and fairly.
